Repligen Corporation (NASDAQ:RGEN) Holdings Decreased by Vanguard Group Inc.

Vanguard Group Inc. trimmed its position in Repligen Corporation (NASDAQ:RGEN – Free Report) by 0.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,079,894 shares of the biotechnology company’s stock after selling 21,196 shares during the quarter. Vanguard Group Inc. owned approximately 0.09% […]

Leave a Reply

Your email address will not be published.

Previous post Trex Company, Inc. (NYSE:TREX) Shares Sold by Vanguard Group Inc.
Next post Valmont Industries, Inc. (NYSE:VMI) Position Decreased by Charles Schwab Investment Management Inc.